Wesper Journal

Revolutionizing Obstructive Sleep Apnea Care with Zepbound
Discover how Zepbound® (tirzepatide), the first FDA-approved medication for obstructive sleep apnea (OSA) in adults with obesity, is revolutionizing treatment. Combining effective weight management with symptom relief, Zepbound offers a groundbreaking solution that enhances sleep quality, simplifies care pathways, and improves overall health outcomes. Learn more about this transformative advancement in OSA therapy.
Continue reading

our research

Discover the Wesper Journal

The Wesper Journal is our weekly publication dedicated to exploring sleep apnea, sleep health, and the latest updates from Wesper. Each edition offers expert insights, practical tips, and valuable resources to help you better understand and improve your sleep, empowering you to take control of your sleep health journey.

Managing Sleep Apnea, Diabetes - US Guide
Managing Sleep Apnea, Diabetes - US Guide

Managing sleep apnea and diabetes requires...

READ
Managing Sleep Disorders Effectively
Managing Sleep Disorders Effectively

Effective management of sleep disorders involves...

READ
Greatly Improved Stroke Recovery by Treating Sleep Apnea
Greatly Improved Stroke Recovery by Treating Sleep Apnea

Treating sleep apnea, particularly through CPAP...

READ
The Dangers of Untreated Sleep Apnea
The Dangers of Untreated Sleep Apnea

Sleep apnea, a sleep disorder marked...

READ
Relationship Challenges with Untreated Sleep Apnea
Relationship Challenges with Untreated Sleep Apnea

Obstructive Sleep Apnea (OSA) is a...

READ
Assessment of Wesper Accuracy in Patients with Atrial Fibrillation
Assessment of Wesper Accuracy in Patients with Atrial Fibrillation

Chelsie Rohrscheib, Ph.D. Neuroscientist and Head...

READ
A Second Opinion with Wesper
A Second Opinion with Wesper

In the realm of sleep medicine,...

READ
Uncovering the Truth Behind CPAP Efficacy
Uncovering the Truth Behind CPAP Efficacy

In the realm of sleep medicine, positive...

READ